Switch to
More onapp

How to use scorecard? Learn more

Natco Pharma Ltd

NATCOPHARM
Health CarePharmaceuticals
SmallcapWith a market cap of ₹25,080 cr, stock is ranked 307
Moderate RiskStock is 2.48x as volatile as Nifty
1,353.958.75 (-0.64%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Avg

Financials growth has been moderate for a few years

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹25,080 cr, stock is ranked 307
Moderate RiskStock is 2.48x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
15.33
PB RatioPB Ratio
4.29
Dividend YieldDiv. Yield
Sector PESector PE
51.91
Sector PBSector PB
6.64
Sector Div YldSctr Div Yld
0.47%

Forecast & RatingsDetailed Forecast 

56%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Natco Pharma Limited is a research and development (R&D)-focused pharmaceutical company. The Company is engaged in developing, manufacturing and marketing finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs).

Brands

Natco Pharma

Pharmaceutical company

Brands

Natco Pharma

Pharmaceutical company

Financial TrendFinancial statements 

20212022202320242.162.042.814.130.440.170.721.39
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Decreased Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has decreased by 1.41%

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Shareholders meeting 
Announced OnOct 1, 2024

Natco Pharma Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 30, 2024 | Download

Natco Pharma Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 30, 2024 | Download

Shareholders meeting 
Announced OnSep 30, 2024

Natco Pharma Limited has informed the Exchange regarding Proceedings of 41st Annual General Meeting held on September 30, 2024 | Download

Natco Pharma Limited has informed the Exchange regarding Proceedings of 41st Annual General Meeting held on September 30, 2024 | Download

Cash Dividend 
Ex. DateAug 23, 2024

Interim • Div/Share: ₹ 3

See all events